Plasmodium falciparum: DNA sequence specificity of cisplatin and cisplatin analogues

Experimental Parasitology

Volumn 128, Issue 4, 2011, Pages 396-400

  Murray, Vincent ^a   Campbell, Heather M ^a   Gero, Annette M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Carboplatin; DNA targeted analogues; Malaria; Repeat sequence; Transplatin

Indexed keywords

CARBOPLATIN; CELL DNA; CISPLATIN; CISPLATIN DERIVATIVE; GUANINE; REPETITIVE DNA; TRANSPLATIN;

ANTIMALARIAL ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA REPLICATION; DNA SEQUENCE; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG STRUCTURE; GENE TARGETING; GENOME ANALYSIS; HUMAN; HUMAN CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TELOMERE; TROPHOZOITE;

ANTIMALARIALS; CARBOPLATIN; CISPLATIN; DNA ADDUCTS; DNA DAMAGE; DNA, PROTOZOAN; ERYTHROCYTES; HUMANS; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 79960554580     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.05.002     Document Type: Article

References (37)

1. Boulikas T., Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncology Reports 2004, 11:559-595.
2. Bruhn S.L., Pil P.M., Essigmann J.M., Housman D.E., Lippard S.J. Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:2307-2311.
3. Cairns M.J., Carland M., McFadyen W.D., Denny W.A., Murray V. The DNA sequence selectivity of maltolato-containing cisplatin analogues in purified plasmid DNA and in intact human cells. Journal of Inorganic Biochemistry 2009, 103:1151-1155.
4. Dluzewski A.R., Ling I.T., Rangachari K., Bates P.A., Wilson R.J. A simple method for isolating viable mature parasites of Plasmodium falciparum from cultures. Transactions of the Royal Society of Tropical Medicine and Hygiene 1984, 78:622-624.
5. Dondorp A.M., Yeung S., White L., Nguon C., Day N.P., Socheat D., von Seidlein L. Artemisinin resistance: current status and scenarios for containment. Nature Reviews Microbiology 2010, 8:272-280.
6. Fichtinger-Schepman A.M., van der Veer J.L., den Hartog J.H., Lohman P.H., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 1985, 24:707-713.
7. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.-S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M.A., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
8. Giha H.A. Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope. Parasitology Research 2010, 106:549-552.
9. Hastings I. How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance. Trends in Parasitology 2011, 27:67-72.
10. Holmes R.J., McKeage M.J., Murray V., Denny W.A., McFadyen W.D. Cis-dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro. Journal of Inorganic Biochemistry 2001, 85:209-217.
11. Jung Y., Lippard S.J. Direct cellular responses to platinum-induced DNA damage. Chemical Reviews 2007, 107:1387-1407.
12. Kelland L.R. The resurgence of platinum-based cancer chemotherapy. Nature Reviews Cancer 2007, 7:573-584.
13. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. Journal of Parasitology 1979, 65:418-420.
14. Lee H.H., Palmer B.D., Baguley B.C., Chin M., McFadyen W.D., Wickham G., Thorsbourne-Palmer D., Wakelin L.P.G., Denny W.A. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II). Journal of Medicinal Chemistry 1992, 35:2983-2987.
15. Loehrer P.J., Einhorn L.H. Drugs five years later. Cisplatin. Annals of Internal Medicine 1984, 100:704-713.
16. Muregi, F.W., Kirira, P.G., Ishih, A., 2010. Novel rational drug design strategies with potential to revolutionize malaria chemotherapy. Current Medicinal Chemistry.
17. Murray V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Research 1989, 17:8889.
18. Murray V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on anti-tumour agents (review). Progress in Nucleic Acid Research and Molecular Biology 2000, 63:367-415.
19. Murray V., Motyka H., England P.R., Wickham G., Lee H.H., Denny W.A., McFadyen W.D. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells. Biochemistry 1992, 31:11812-11817.
20. Murray V., Motyka H., England P.R., Wickham G., Lee H.H., Denny W.A., McFadyen W.D. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. Journal of Biological Chemistry 1992, 267:18805-18809.
21. Murray V., Whittaker J.K., McFadyen W.D. DNA sequence selectivity of cisplatin analogues in intact human cells. Chemico Biological Interactions 1998, 110:27-37.
22. Nair L., Bhasin V.K. Cure with cisplatin (II) or murine malaria infection and in vitro inhibition of a chloroquine-resistant Plasmodium falciparum isolate. Japanese Journal of Medical Science and Biology 1994, 47:241-252.
23. Nzila A., Okombo J., Becker R.P., Chilengi R., Lang T., Niehues T. Anticancer agents against malaria: time to revisit?. Trends in Parasitology 2009, 26:125-129.
24. O'Neill P.M., Barton V.E., Ward S.A. The molecular mechanism of action of artemisinin - the debate continues. Molecules 2010, 15:1705-1721.
25. Paccagnella A., Favaretto A., Oniga F., Barbieri F., Ceresoli G., Torri W., Villa E., Verusio C., Cetto G.L., Santo A., De Pangher V., Artioli F., Cacciani G.C., Parodi G., Soresi F., Ghi M.G., Morabito A., Biason R., Giusto M., Mosconi P., Chiarion Sileni V., Gstvp Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung Cancer 2004, 43:83-91.
26. Paul M., Murray V. The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence. Journal of Biological Inorganic Chemistry 2011, 16:735-743.
27. Ponti M., Forrow S.M., Souhami R.L., D'Incalci M., Hartley J.A. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Research 1991, 19:2929-2933.
28. Temple M.D., McFadyen W.D., Holmes R.J., Denny W.A., Murray V. The interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. Biochemistry 2000, 39:5593-5599.
29. Temple M.D., Recabarren P., McFadyen W.D., Holmes R.J., Denny W.A., Murray V. The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells. Biochimica et Biophysica Acta 2002, 1574:223-230.
30. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193:673-675.
31. Turschner S., Efferth T. Drug resistance in Plasmodium: natural products in the fight against malaria. Mini-Reviews in Medicinal Chemistry 2009, 9:206-214.
32. Wang D., Lippard S.J. Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery 2005, 4:307-320.
33. Wasserman M., Contreras J., Pinilla G., Rojas M.O., Paez A., Caminos E. Plasmodium falciparum: characterization of a 0.7-kbp, moderately repetitive sequence. Experimental Parasitology 1995, 81:165-171.
34. Whittaker J.K., McFadyen W.D., Wickham G., Wakelin L.P.G., Murray V. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA. Nucleic Acids Research 1998, 26:3933-3939.
35. Wickstead B., Ersfeld K., Gull K. Repetitive elements in genomes of parasitic protozoa. Microbiology and Molecular Biology Reviews 2003, 67:360-375.
36. Winzeler E.A. Malaria research in the post-genomic era. Nature 2008, 455:751-756.
37. World Health Organisation, 2009. World malaria report. (accessed 19.01.11). http://www.who.int/malaria/publications/atoz/9789241563901/en/index.html.